Source news

reuters News

20 stories
reuters

French biotech Ipsen to buy Memo Therapeutics for $230 million upfront

French biotech company Ipsen EURONEXT:IPN will buy Switzerland-based Memo Therapeutics to add potravitug, a Phase II clinical-stage antibody targeting BK polyomavirus, to its portfolio, the company said on Wednesday.The deal is valued at €200 million ($228.16 million) upfront, with the potential to…

Reuters en
StocksCHFR
reuters

China's Windrose Electric seeks $2 billion US SPAC deal this year, FT reports

China's electric lorry start-up Windrose Electric plans to list its shares in the US this year through a special purpose acquisition company at an enterprise value of at least $2 billion, the company's chief executive Wen Han told the Financial Times in an interview published on Wednesday.Here are…

Reuters en
StocksCNUS